Documents & Charters

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

Luminex is committed to honest, fair and open business conduct and a culture dedicated to these principles. We believe that our stakeholders - customers, partners, investors, employees and vendors - depend on Luminex to conduct its business with ethics and values of a high standard. Corporate governance is a responsibility we take seriously every day. We have taken several steps to establish good corporate governance practices and ensure compliance with the law.

We have implemented a Code of Compliance, including a senior code of conduct, and provide compliance training for all employees and officers; we have revised our Board committee structures and charters to accommodate recent changes in the law, including Sarbanes-Oxley; we have established an internal disclosure committee to review our public financial disclosures; and we have created the Luminex Ethics and Compliance Line for reporting any suspected violations of our Code of Compliance or financial irregularities. Complaints or concerns about accounting, internal accounting controls, auditing or other matters may be reported anonymously or otherwise to our legal department or the Audit Committee in any of the following ways:

  • Log-on to the Luminex Ethics and Compliance Line at
  • Call the Luminex Ethics and Compliance Line toll-free (1-866-363-5400) or text (512-859-6629) in North America.
  • For international calls, call the Luminex Ethics and Compliance Line at +800-1777-9999. If you cannot complete your call, you may also call collect into the U.S. +1720-514-4400. Language translation services will be available
  • The Chairman of the Audit Committee can be reached at 615-804-2601

Shareholder Tools